Staging syndrome differentiation of diabetic retinopathy based on aqueous peptidomics

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033405

Enrollment

Unknown

Registered

2020-05-31

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy

Interventions

Gold Standard:Fundus photography or fluorescein sodium fundus angiography

Index test:Proteomics,&#32

Waters&#32

G2-XS&#32

QTof

Eligibility

Sex/Gender

All

Age

40 Years to 90 Years

Inclusion criteria

Inclusion criteria: The surgical patients of ophthalmology in hospital mainly include cataract surgery and diabetic retinopathy surgery.

Exclusion criteria

Exclusion criteria: Malignant tumors and autoimmune diseases; secondary diabetes and gestational diabetes, hypertensive retinopathy, iris and ciliary body disease, glaucoma.

Design outcomes

Primary

Measure	Time frame
aqueous peptidomics;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactHao Liang

Hunan University of Chinese Medicine

lianghao@hnucm.edu.cn+86 13975863601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026